Akso Health Group (FRA:8HX)
Germany · Delayed Price · Currency is EUR 1.260
-0.050 (-3.82%)
At close: Nov 28, 2025
Akso Health Group Income Statement
Financials in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Operating Revenue | 14.78 | 2.41 | 13.18 | 6 | - | Upgrade |
| 14.78 | 2.41 | 13.18 | 6 | - | Upgrade | |
Revenue Growth (YoY) | 512.09% | -81.68% | 119.69% | - | - | Upgrade |
Cost of Revenue | 15.06 | 2.29 | 11.91 | 5.39 | - | Upgrade |
Gross Profit | -0.28 | 0.12 | 1.27 | 0.61 | - | Upgrade |
Selling, General & Admin | 3.64 | 8.76 | 15.54 | 2.67 | 2.03 | Upgrade |
Operating Expenses | 3.64 | 8.76 | 15.54 | 3.06 | 2.09 | Upgrade |
Operating Income | -3.92 | -8.64 | -14.27 | -2.46 | -2.09 | Upgrade |
Interest Expense | - | - | - | -0.8 | -2.15 | Upgrade |
Currency Exchange Gain (Loss) | -0 | -0.59 | 1.14 | -0.75 | - | Upgrade |
Other Non Operating Income (Expenses) | 0.03 | 0.14 | 0.06 | 0 | -0.05 | Upgrade |
EBT Excluding Unusual Items | -3.89 | -9.09 | -13.07 | -4.01 | -4.29 | Upgrade |
Impairment of Goodwill | -41.37 | - | - | - | - | Upgrade |
Asset Writedown | -121.01 | - | - | - | - | Upgrade |
Pretax Income | -166.27 | -9.09 | -13.07 | -4.01 | -4.29 | Upgrade |
Income Tax Expense | -30.8 | 0.02 | 0.02 | 0.09 | - | Upgrade |
Earnings From Continuing Operations | -135.47 | -9.12 | -13.08 | -4.1 | -4.29 | Upgrade |
Earnings From Discontinued Operations | - | -0.4 | 11.84 | -12.75 | -30.53 | Upgrade |
Net Income to Company | -135.47 | -9.52 | -1.25 | -16.85 | -34.83 | Upgrade |
Minority Interest in Earnings | 0.49 | 0.06 | -0.11 | -0 | - | Upgrade |
Net Income | -134.98 | -9.46 | -1.36 | -16.85 | -34.83 | Upgrade |
Net Income to Common | -134.98 | -9.46 | -1.36 | -16.85 | -34.83 | Upgrade |
Shares Outstanding (Basic) | 285 | 47 | 23 | 20 | 16 | Upgrade |
Shares Outstanding (Diluted) | 285 | 47 | 23 | 20 | 16 | Upgrade |
Shares Change (YoY) | 504.37% | 106.30% | 15.07% | 22.06% | 0.17% | Upgrade |
EPS (Basic) | -0.47 | -0.20 | -0.06 | -0.85 | -2.14 | Upgrade |
EPS (Diluted) | -0.48 | -0.22 | -0.08 | -0.85 | -2.15 | Upgrade |
Free Cash Flow | 1.02 | 1.35 | -3.25 | -8.63 | 10.06 | Upgrade |
Free Cash Flow Per Share | 0.00 | 0.03 | -0.14 | -0.43 | 0.62 | Upgrade |
Gross Margin | -1.91% | 5.06% | 9.63% | 10.09% | - | Upgrade |
Operating Margin | -26.55% | -357.78% | -108.23% | -40.94% | - | Upgrade |
Profit Margin | -913.38% | -391.77% | -10.32% | -280.85% | - | Upgrade |
Free Cash Flow Margin | 6.92% | 55.97% | -24.68% | -143.81% | - | Upgrade |
EBITDA | -1.77 | - | -14.25 | -2.44 | -2.07 | Upgrade |
EBITDA Margin | -12.00% | - | -108.09% | -40.63% | - | Upgrade |
D&A For EBITDA | 2.15 | - | 0.02 | 0.02 | 0.02 | Upgrade |
EBIT | -3.92 | -8.64 | -14.27 | -2.46 | -2.09 | Upgrade |
EBIT Margin | -26.55% | - | -108.23% | -40.94% | - | Upgrade |
Revenue as Reported | 14.78 | 2.41 | 13.18 | 6 | - | Upgrade |
Advertising Expenses | - | 0.17 | 0.01 | - | - | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.